Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Retraction: Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells

  • The PLOS ONE Editors

Retraction: Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells

  • The PLOS ONE Editors
PLOS
x

The author Sangita Baxi and a Pfizer representative contacted the editorial office to raise that there are image duplications in this article. Pfizer has undertaken a review and determined that there are duplications in Fig 1 and Fig 2 of the article and that part of the experiments cannot be verified.

In light of the concerns identified, the authors and the PLOS ONE Editors retract this article. We did not receive any response or comment from Min-Jean Yin, Wei Tan, or Tod Smeal.

Reference

  1. 1. Baxi SM, Tan W, Murphy ST, Smeal T, Yin M-J (2012) Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells. PLoS ONE 7(10): e48402. pmid:23119004